Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.

NCT02118051 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

234

Enrollment

OTHER

Sponsor class

Conditions

Infertility

Interventions

DRUG: Ganirelix 0.25 mg.
DRUG: Recombinant choriogonadotropin alfa
DRUG: Micronized natural progesterone.

Sponsor

Instituto de Investigacion Sanitaria La Fe